TetraLogic Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2012 | 0 | -16.19M | |
|---|---|---|---|
| 2013 | 0 | -22.71M | |
| 2014 | 0 | -39.31M | |
| 2015 | 0 | -56.10M | |
| 2019 | 0 | 0 | |
| 2020 | 0 | 0 | |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
TLOG Income Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 187.99K | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | -187.99K | 0 | 0 | 0 |
Operating exp. | ||||||||
Research and development | 0 | 0 | 0 | 0 | 27.40M | 20.28M | 9.52M | 12.09M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 0 | 0 | 0 | 0 | 38.50M | 31.21M | 17.99M | 16.17M |
Operating income | 0 | 0 | 0 | 0 | -44.99M | -33.78M | -17.99M | -16.17M |
Other income (expenses), net | 0 | 0 | 0 | 0 | -11.22M | -4.74M | -1.95M | -27.52K |
Income before tax | 0 | 0 | 0 | 0 | -49.72M | -35.95M | -19.95M | -16.19M |
Income tax expense | 0 | 0 | 0 | 0 | 6.38M | 3.35M | 2.76M | 0 |
Net income | 0 | 0 | 0 | 0 | -56.10M | -39.31M | -22.71M | -16.19M |
Earnings per share | ||||||||
Basic EPS | 0 | 0 | 0 | 0 | -2.37 | -1.76 | -9.9 | -1.52 |
Diluted EPS | 0 | 0 | 0 | 0 | -2.36 | -1.76 | -9.9 | -1.52 |